Skip to main content
SpringerLink
Log in

Metabolic Syndrome in South Asians

  • Reference work entry
  • First Online:
Metabolic Syndrome

  • 3478 Accesses

Abstract

Cardiovascular disease (CVD) is an important global health problem causing significant morbidity, disability, and premature mortality. The overall impact of CVD on the society is enormous – chronic disease burden, frequent hospitalizations, loss of productivity, and impairment of quality of life. While multiple individual risk factors such as hypertension, diabetes, hyperlipidemia, obesity, and tobacco consumption can cause CVD, it is the constellation of these risk factors (termed metabolic syndrome) which creates the milieu for atherosclerosis and other manifestations of CVD. The problem of metabolic syndrome is escalating all over the world irrespective of cultural, genetic, gender, and geographical differences. Thus, metabolic syndrome can be labeled as a merciless equal opportunity killer. This chapter covers the epidemiology of metabolic syndrome in South Asians and the implications for the society. The escalating prevalence and degree of metabolic syndrome in South Asians required applicable public health interventions at the societal level to decrease chronic disease burden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Abate N, et al. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab. 2003;88(12):5927-5934.

    Google Scholar 

  • Abbasi F, et al. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 2002;40(5):937-943.

    Google Scholar 

  • Alberti KG, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645.

    Google Scholar 

  • Ballantyne CM, et al. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation. 2001;104(25):3046-3051.

    Google Scholar 

  • Basit A, Shera AS. Prevalence of metabolic syndrome in Pakistan. Metab Syndr Relat Disord. 2008;6:171-175.

    Google Scholar 

  • Bhalodkar NC, et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol. 2004;94(12):1561-1563.

    Google Scholar 

  • Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97(7):1007-1009.

    Google Scholar 

  • Bhopal RS. Heterogeneity among Indians, Pakistanis, and Bangladeshis is key to racial inequities. BMJ. 2002;325(7369):903.

    Google Scholar 

  • Cappuccio FP, et al. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart. 1997;78(6):555-563.

    Google Scholar 

  • Chambers JC, et al. Abnormalities of vascular endothelial function may contribute to increased coronary heart disease risk in UK Indian Asians. Heart. 1999;81(5):501-504.

    Google Scholar 

  • Chiu KC, et al. Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians. BMC Genet. 2000;1:2.

    Google Scholar 

  • Cromwell WC. High-density lipoprotein associations with coronary heart disease: does measurement of cholesterol content give the best result? J Clin Lipidol. 2007;1(1):57-64.

    Google Scholar 

  • Donati MB. The “common soil hypothesis”: evidence from population studies? Thromb Res. 2010;125(Suppl 2):S92-S95.

    Google Scholar 

  • Eckel RH, et al. The metabolic syndrome. Lancet. 2010;375(9710):181-183.

    Google Scholar 

  • Enas EA, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48(4):343-353.

    Google Scholar 

  • Enas EA, et al. Elevated lipoprotein(a) – a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review. Dis Mon. 2006;52(1):5-50.

    Google Scholar 

  • Farmer JA, Liao J. Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis. Curr Atheroscler Rep. 2011;13(2):107-114.

    Google Scholar 

  • Ferrannini E, et al. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34(6):416-422.

    Google Scholar 

  • Ghosh A. Effects of socio-economic and behavioural characteristics in explaining central obesity – a study on adult Asian Indians in Calcutta. India Coll Antropol. 2006;30(2):265-271.

    Google Scholar 

  • Grundy SM, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-438.

    Google Scholar 

  • Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-2752.

    Google Scholar 

  • Gupta R. Meta-analysis of prevalence of hypertension in India. Indian Heart J. 1997;49(1):43-48.

    Google Scholar 

  • Gupta A, et al. Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population. Diabetes Res Clin Pract. 2003;61(1):69-76.

    Google Scholar 

  • Joseph A, Kutty VR, Soman CR. High risk for coronary heart disease in Thiruvananthapuram city: a study of serum lipids and other risk factors. Indian Heart J. 2000;52(1):29-35.

    Google Scholar 

  • Kain K, Catto AJ, Grant PJ. Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects. Diabet Med. 2003;20:651-655.

    Google Scholar 

  • Keech A, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366(9500):1849-1861.

    Google Scholar 

  • King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-1431.

    Google Scholar 

  • Knowler WC, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686.

    Google Scholar 

  • Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385-411.

    Google Scholar 

  • Liu J, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care. 2005;28(8):1916-1921.

    Google Scholar 

  • Loke YK, Kwok CS, Singh S. Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ. 2011;342:d1309.

    Google Scholar 

  • Manttari M, et al. Lipoproteins and coronary heart disease in the Helsinki Heart Study. Eur Heart J. 1990;11(Suppl H):26-31.

    Google Scholar 

  • McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337(8738):382-386.

    Google Scholar 

  • Miller M, et al. APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome. Arch Med Res. 2007;38(4):444-451.

    Google Scholar 

  • Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes Relat Metab Disord. 2003;27(11):1294-1296.

    Google Scholar 

  • Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S9-S30.

    Google Scholar 

  • Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009;7(6):497-514.

    Google Scholar 

  • Misra A, Misra R, Wijesuriya M. The metabolic syndrome in South Asians. In: Mohan V, Rao GHR, eds. Type 2 Diabetes in South Asians. Epidemiology, Risk Factors and Prevention. Jaypee Bros; 2007:76-96.

    Google Scholar 

  • Misra A, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009a;57:163-170.

    Google Scholar 

  • Misra A, et al. South Asian diets and insulin resistance. Br J Nutr. 2009b;101(4):465-473.

    Google Scholar 

  • Mohan B, et al. Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana. Indian Heart J. 2004;56(4):310-314.

    Google Scholar 

  • Murphy C, et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol. 2007;27(4):936-942.

    Google Scholar 

  • Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med. 2010;170(14):1191-1201.

    Google Scholar 

  • Popkin BM, et al. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr Rev. 2001;59(12):379-390.

    Google Scholar 

  • Radhika G, et al. Dietary salt intake and hypertension in an urban south Indian population – [CURES – 53]. J Assoc Physicians India. 2007;55:405-411.

    Google Scholar 

  • Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094-1101.

    Google Scholar 

  • Ramachandran A, et al. Metabolic syndrome in urban Asian Indian adults – a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60(3):199-204.

    Google Scholar 

  • Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.

    Google Scholar 

  • Reaven GM. The metabolic syndrome: time to get off the merry-go-round? J Intern Med. 2011;269(2):127-136.

    Google Scholar 

  • Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97(6):596-601.

    Google Scholar 

  • Scanu AM. Lp(a) lipoprotein – coping with heterogeneity. N Engl J Med. 2003;349(22):2089-2090.

    Google Scholar 

  • Schernthaner G, Chilton RJ. Cardiovascular risk and thiazolidinediones – what do meta-analyses really tell us? Diabetes Obes Metab. 2010;12(12):1023-1035.

    Google Scholar 

  • Sirtori CR, et al. Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. Nutr Metab Cardiovasc Dis. 2005;15(1):47-55.

    Google Scholar 

  • Sleight P, et al. Blood-pressure reduction and cardiovascular risk in HOPE study. Lancet. 2001;358(9299):2130-2131.

    Google Scholar 

  • Smelt AH, de Beer F. Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects. Semin Vasc Med. 2004;4(3):249-257.

    Google Scholar 

  • Superko HR, et al. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Am J Cardiol. 2005;96(9):1266-1272.

    Google Scholar 

  • Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.

    Google Scholar 

  • Vikram NK, et al. Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk. Nutrition. 2003;19(6):503-509.

    Google Scholar 

  • Wasir JS, Misra A. The Metabolic Syndrome in Asian Indians: Impact of Nutritional and Socio-economic Transition in India. Metab Syndr Relat Disord. 2004;2(1):14-23.

    Google Scholar 

  • Wasir JS, Misra A, Vikram NK, et al. C-reactive protein, obesity, and insulin resistance in postmenopausal women in urban slums of North India. Diabet Metab Syndr Clin Res Rev. 2007;1:83-89.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ram Manohar Lohia Hospital and Post Graduate Institute, New Delhi, India

    Mohsin Wali

  2. Apollo Institute for Blood Pressure Management, Apollo Blood Pressure Clinics, Apollo Hospital, Hyderabad, Telangana, India

    C. Venkata S. Ram

  3. Texas Blood Pressure Institute, University of Texas Southwestern Medical School, Dallas, TX, USA

    C. Venkata S. Ram

  4. MediCiti Institute of Medical Sciences, Hyderabad, India

    C. Venkata S. Ram

  5. Dallas Nephrology Associates, Dallas, TX, USA

    C. Venkata S. Ram

Authors
  1. Mohsin Wali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Venkata S. Ram
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Venkata S. Ram .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Rexford S. Ahima

  2. Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, USA

    Rexford S. Ahima

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this entry

Cite this entry

Wali, M., Ram, C.V.S. (2016). Metabolic Syndrome in South Asians. In: Ahima, R.S. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-11251-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-11251-0_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-11250-3

  • Online ISBN: 978-3-319-11251-0

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation